tiprankstipranks
Trending News
More News >
Appili Therapeutics Inc Class A (APLIF)
OTHER OTC:APLIF
US Market

Appili Therapeutics Inc Class A (APLIF) Financial Statements

Compare
82 Followers

Appili Therapeutics Inc Class A Financial Overview

Appili Therapeutics Inc Class A's market cap is currently $1.75M. The company's EPS TTM is $-0.005759496; its P/E ratio is -1.13; Appili Therapeutics Inc Class A is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 24Dec 23Dec 22Dec 20
Income Statement
Total RevenueC$ 827.41KC$ 100.44KC$ 334.18KC$ 1.39MC$ 0.00
Gross ProfitC$ 827.41KC$ 100.44KC$ 327.91KC$ 1.39MC$ -14.84K
Operating IncomeC$ -2.16MC$ -190.84KC$ -7.91MC$ -24.68MC$ -16.30M
EBITDAC$ -2.07MC$ 360.57KC$ -8.10MC$ -23.51MC$ -14.87M
Net IncomeC$ -3.78MC$ -2.62MC$ -9.24MC$ -25.12MC$ -14.33M
Balance Sheet
Cash & Short-Term InvestmentsC$ 94.49KC$ 1.23MC$ 2.47MC$ 6.66MC$ 16.12M
Total AssetsC$ 1.49MC$ 3.03MC$ 3.13MC$ 8.28MC$ 18.32M
Total DebtC$ 8.18MC$ 12.29MC$ 7.67MC$ 4.98MC$ 1.03M
Net DebtC$ 8.09MC$ 11.07MC$ 5.20MC$ -1.69MC$ -10.03M
Total LiabilitiesC$ 12.42MC$ 16.43MC$ 10.53MC$ 11.55MC$ 5.56M
Stockholders' EquityC$ -10.92MC$ -13.40MC$ -7.40MC$ -3.27MC$ 12.75M
Cash Flow
Free Cash FlowC$ -2.49MC$ 866.46KC$ -10.10MC$ -19.08MC$ -11.46M
Operating Cash FlowC$ -2.46MC$ 868.82KC$ -10.10MC$ -19.08MC$ -11.45M
Investing Cash FlowC$ -29.06KC$ -2.36KC$ -3.17KC$ 5.06MC$ -4.99M
Financing Cash FlowC$ 122.05KC$ 193.68KC$ 5.91MC$ 9.56MC$ 17.02M
Currency in CAD

Appili Therapeutics Inc Class A Earnings and Revenue History

Appili Therapeutics Inc Class A Debt to Assets

Appili Therapeutics Inc Class A Cash Flow

Appili Therapeutics Inc Class A Forecast EPS vs Actual EPS